Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

INCREASED EXPRESSION OF V-DOMAIN IG SUPPRESSOR OF T-CELL ACTIVATION (VISTA) ON LEUKOCYTES OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) PATIENTS

Autor: Cadena, R. Hid, Yuan, J., Huitema, M. G., Boots, A. M., Stegeman, C., Brouwer, E., Rutgers, A., Heeringa, P., Abdulahad, W. H.

Publikováno v: Annals of the Rheumatic Diseases, 77, 782-783. BMJ PUBLISHING GROUP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::e07f4e0d0d0c50c0f320df5298d31bfc
https://research.rug.nl/en/publications/d8841fd2-5770-4a74-a321-f5f7487a830e

INCREASED EXPRESSION OF MIR142-3P MAY EXPLAIN THE FUNCTIONAL DEFECT OF REGULATORY T-CELLS IN ANCA ASSOCIATED VASCULITIS

Autor: Bijma, T., Dekkema, G. J., Abdulahad, W., Den Berg, A., Kroesen, B. J., Stegeman, C. A., Peter Heeringa, Sanders, J. S.

Publikováno v: Rheumatology, 56, 122-122. Oxford University Press
Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::11d83fbbef71f63f3689a5b76dcdba4d
https://research.rug.nl/en/publications/e6f13afd-6bc6-4e65-85b6-af81d7acee35

Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise

Autor: Aydin, S. Z., Direskeneli, H., Merkel, P. A., Toloza, S., Blockmans, D., Sato, E. I., De Souza, A. W. S., Cabral, D., Carette, S., Famorca, L., Khalidi, N., Milman, N., Yacyshyn, E., Tesar, V., Baslund, B., Faurschou, M., Guillevin, L., Puechal, X., Aries, P., Hellmich, B., Herlyn, K., Holle, J., Lamprecht, P., Moosig, F., Neumann, T., Zwerina, J., Tomasson, G., Bambery, P., Jois, R., Rajasekhar, L., Sharma, A., Sivakumar, R., Molloy, E., Hashkes, P., Catapano, F., Cimino, L., De Fanti, A., Pipitone, N., Salvarani, C., Vaglio, A., Kobayashi, S., Suzuki, K., Flores-Suarez, L. F., Hinojosa-Azaola, A., Brouwer, E., Rutgers, A., Stegeman, C., Suppiah, R., Hollan, I., Arguis, P., Cid, M. C., Daikeler, T., Alibaz-Oner, F., Hamuryudan, V., Hatemi, G., Hazirolan, T., Inanc, M., Kalayci, M. B., Kamali, S., Kansu, T., Karaaslan, Y., Karadag, O., Keser, G., Onat, A. M., Ozbalkan, Z., Ozen, S., Ozer, H. T. E., Pamuk, O. N., Yilmaz, S. G., Basu, N., Casian, A., Chakravarty, K., D'Cruz, D., Edelsten, C., Harper, L., Jayne, D., Levy, J., Mason, J., Robson, J., Scott, D., Stanford, M., Watts, R., Albert, D., Amudala, N., Beckman, J., Chacko, B., Chung, S., Fessler, B., Giardino, A., Grayson, P., Hunder, G., Langford, C., Lerman, M., Liang, K., Litt, H., Mason, T., Matteson, E., Mikdashi, J., Mohler, E., Monach, P., Rice, B., Sreih, A., Stone, J., Tsapatsaris, N., Villa-Forte, A., Warrington, K., Yazici, Y., Ytterberg, S.

PubMedID: 28864648 Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f5ad03ab4996a273ea0dc71a344be2
https://hdl.handle.net/20.500.12605/11289